Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy

Detalles Bibliográficos
Autores principales: Slavcev, Antonij, Süsal, Caner, Doxiadis, Ilias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294921/
https://www.ncbi.nlm.nih.gov/pubmed/35865533
http://dx.doi.org/10.3389/fimmu.2022.968668
_version_ 1784749952195362816
author Slavcev, Antonij
Süsal, Caner
Doxiadis, Ilias
author_facet Slavcev, Antonij
Süsal, Caner
Doxiadis, Ilias
author_sort Slavcev, Antonij
collection PubMed
description
format Online
Article
Text
id pubmed-9294921
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92949212022-07-20 Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy Slavcev, Antonij Süsal, Caner Doxiadis, Ilias Front Immunol Immunology Frontiers Media S.A. 2022-07-05 /pmc/articles/PMC9294921/ /pubmed/35865533 http://dx.doi.org/10.3389/fimmu.2022.968668 Text en Copyright © 2022 Slavcev, Süsal and Doxiadis https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Slavcev, Antonij
Süsal, Caner
Doxiadis, Ilias
Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
title Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
title_full Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
title_fullStr Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
title_full_unstemmed Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
title_short Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
title_sort editorial: t-cell and antibody-mediated rejection after organ transplantation in the post-covid-19 era – diagnosis, immunological risk evaluation and therapy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294921/
https://www.ncbi.nlm.nih.gov/pubmed/35865533
http://dx.doi.org/10.3389/fimmu.2022.968668
work_keys_str_mv AT slavcevantonij editorialtcellandantibodymediatedrejectionafterorgantransplantationinthepostcovid19eradiagnosisimmunologicalriskevaluationandtherapy
AT susalcaner editorialtcellandantibodymediatedrejectionafterorgantransplantationinthepostcovid19eradiagnosisimmunologicalriskevaluationandtherapy
AT doxiadisilias editorialtcellandantibodymediatedrejectionafterorgantransplantationinthepostcovid19eradiagnosisimmunologicalriskevaluationandtherapy

Ejemplares similares